Condition
Blue Rubber Bleb Nevus Syndrome
Total Trials
3
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Unknown1
Active Not Recruiting1
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT02399527Recruiting
Lymphatic Anomalies Registry for the Assessment of Outcome Data
NCT06642051Not ApplicableActive Not Recruiting
Safety of the Sonablate HIFU System for the Ablation of Incompetent Veins of the Periphery
NCT03767660Phase 4UnknownPrimary
Efficacy of Rapamycin (Sirolimus) in the Treatment of BRBNS, Hereditary or Sporadic Venous Malformation
Showing all 3 trials